Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prostacyclin receptor | ||
Ligand | BDBM50020044 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1363801 (CHEMBL3294218) | ||
IC50 | 1000±n/a nM | ||
Citation | Zhou, G; Zorn, N; Ting, P; Aslanian, R; Lin, M; Cook, J; Lachowicz, J; Lin, A; Smith, M; Hwa, J; van Heek, M; Walker, S Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors. ACS Med Chem Lett5:544-9 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Prostacyclin receptor | |||
Name: | Prostacyclin receptor | ||
Synonyms: | PGI receptor | PI2R_HUMAN | PRIPR | PTGIR | Prostacyclin (IP) Receptor | Prostacyclin receptor | Prostaglandin I | Prostaglandin I2 | Prostaglandin I2 receptor | Prostanoid IP receptor | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 40968.22 | ||
Organism: | Homo sapiens (Human) | ||
Description: | The membranes prepared from human platelet were used in binding assay. | ||
Residue: | 386 | ||
Sequence: |
| ||
BDBM50020044 | |||
n/a | |||
Name | BDBM50020044 | ||
Synonyms: | CHEMBL3287898 | ||
Type | Small organic molecule | ||
Emp. Form. | C32H36N2O4 | ||
Mol. Mass. | 512.6392 | ||
SMILES | CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2cc(ccc12)-c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1 |r,wU:28.31,13.14,wD:31.35,(3.45,-11.77,;3.48,-13.31,;4.83,-14.05,;4.86,-15.59,;6.21,-16.33,;7.53,-15.52,;7.49,-13.98,;6.14,-13.26,;6.11,-11.72,;7.42,-10.91,;8.77,-11.65,;7.38,-9.37,;6.03,-8.64,;6,-7.1,;4.65,-6.36,;7.32,-6.29,;8.67,-7.04,;9.98,-6.23,;11.33,-6.98,;11.37,-8.52,;10.06,-9.31,;8.7,-8.58,;12.65,-6.17,;14,-6.92,;15.31,-6.11,;15.27,-4.57,;13.92,-3.84,;12.61,-4.63,;16.59,-3.78,;16.55,-2.23,;17.87,-1.43,;19.22,-2.18,;20.53,-1.37,;21.88,-2.1,;23.19,-1.3,;21.92,-3.64,;19.26,-3.72,;17.94,-4.51,)| | ||
Structure |